Dreamgenics 
The term Diabetes Mellitus (DM) describes a complex metabolic disorder characterized by chronic hyperglycemia as a result of insufficient insulin secretion and/or decreased tissue response to insulin, resulting in abnormally high blood glucose concentrations. The etiology of the disease is very ... Read More
APACI and Dreamgenics have signed a framework agreement of institutional collaboration to promote the genetic diagnosis of congenital cardiovascular diseases, as well as to develop research projects and training activities related to them. The Asociación de Padres y Amigos de Cardiopatías Congénitas (APACI) is an association of public utility, national and independent that watches over and promotes the ... Read more
CNVs (Copy Number Variations) are a type of submicroscopic-sized structural variants, such as deletions, duplications, insertions, inversions and translocations, which involve a change in copy number with respect to the reference genome (Figure 1). Although they are relatively common in the structure of our genomes and contribute greatly to the variability ... Read More
Since its appearance just over a decade ago, we have witnessed how RNA-Seq technology has revolutionized our knowledge of the transcriptome. This methodology performs an estimation of gene expression based on the number of RNA fragments from sequencing that align with a given region of a genome ... Read More
The Foundation for Biosanitary Research and Innovation of Asturias (FINBA) and Dreamgenics have signed a framework agreement of institutional collaboration for the scientific-technological development and biosanitary innovation in Asturias with the aim of carrying out research projects in the field of Personalized Precision Medicine. FINBA has ... Read more
Dreamgenics has as a fundamental objective of its activity as a biotechnology company to collaborate in the development of Precision Medicine, and to achieve this, it is essential to establish close links with prestigious institutions and research centers. For this reason, it has reached a collaboration agreement with the European University. With this collaboration, both institutions will ... Read more
Rheumatoid arthritis (RA) is a multifactorial, inflammatory and progressive autoimmune disease, most commonly found in people between the ages of 45 and 55, which mainly affects the joints, although it can also affect other parts of the body. It begins with a destruction of the synovial membrane that covers the joints, causing a picture of pain, swelling and ... Read More
The development of omics technologies in recent years has led to an increasing understanding of the pathophysiology of diseases and the discovery of potential biomarkers that can improve the diagnosis, prognosis and monitoring of how a disease responds to different treatments. This increase in the number of possible variables involved in the onset of disease is ... Read More